These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 38227150)

  • 1. The emerging roles of histone demethylases in cancers.
    Tong D; Tang Y; Zhong P
    Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of histone demethylases in cancer therapy.
    Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
    Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone demethylases set the stage for cancer metastasis.
    Cao J; Yan Q
    Sci Signal; 2013 Apr; 6(273):pe15, 1-2. PubMed ID: 23633674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone lysine demethylases as targets for anticancer therapy.
    Højfeldt JW; Agger K; Helin K
    Nat Rev Drug Discov; 2013 Dec; 12(12):917-30. PubMed ID: 24232376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting LSD1 in cancer: Molecular elucidation and recent advances.
    Cai W; Xiao C; Fan T; Deng Z; Wang D; Liu Y; Li C; He J
    Cancer Lett; 2024 Aug; 598():217093. PubMed ID: 38969160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting histone lysine demethylases - progress, challenges, and the future.
    Thinnes CC; England KS; Kawamura A; Chowdhury R; Schofield CJ; Hopkinson RJ
    Biochim Biophys Acta; 2014 Dec; 1839(12):1416-32. PubMed ID: 24859458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting histone demethylases in cancer therapy.
    Grant S
    Clin Cancer Res; 2009 Dec; 15(23):7111-3. PubMed ID: 19934292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapies by targeting aberrant histone methylome in AML: molecular mechanisms, current preclinical and clinical development.
    Tsai CT; So CW
    Oncogene; 2017 Mar; 36(13):1753-1759. PubMed ID: 27593928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
    Tian X; Zhang S; Liu HM; Zhang YB; Blair CA; Mercola D; Sassone-Corsi P; Zi X
    Curr Cancer Drug Targets; 2013 Jun; 13(5):558-79. PubMed ID: 23713993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Lysine Demethylase Inhibitors.
    Jambhekar A; Anastas JN; Shi Y
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 28049654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
    Gelato KA; Adler D; Ocker M; Haendler B
    Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic agents in combined anticancer therapy.
    Kejík Z; Jakubek M; Kaplánek R; Králová J; Mikula I; Martásek P; Král V
    Future Med Chem; 2018 May; 10(9):1113-1130. PubMed ID: 29676175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.